Minneapolis News
-
Updated 37 minutes ago
Gap Inc. fell as much as 5 percent in late trading after the retailer forecast annual profit that was less than analysts estimated.
-
Updated 2 hours, 15 minutes ago
Merck & Co. said it will end development of the experimental drug preladenant for Parkinson’s disease because a preliminary review of the data from late-stage clinical trials suggests it doesn’t work.
-
Updated 1 hour, 54 minutes ago
Kari Antin, a 40-year-old financial analyst in Minneapolis, knows she’s taking a life-or-death risk with every monthly infusion of Biogen Idec Inc.’s Tysabri.
-
Updated 3 hours, 19 minutes ago
Johnson & Johnson, the world’s biggest maker of health-care products, anticipates submitting more than 10 new medicines for approval by regulators worldwide by 2017, including a modified version of a decades-old anesthetic that has been misused as a date-rape drug.
-
Natural gas futures have reversed a two-year downtrend over the past several weeks and may top $5 in the third quarter, according to a technical analysis by Piper Jaffray Cos.
-
Target Corp., the second-largest U.S. discount retailer, said first-quarter earnings fell 29 percent and cut its forecast for profit this year as higher taxes and cooler temperatures hampered sales.
-
Boston Scientific Corp.’s Lotus device, inserted through a catheter into the heart to fix a damaged aortic valve, was safely implanted without any severe leakage in a study being conducted for European approval.
-
Following are the minutes of the Federal Reserve’s Open Market Committee meeting that concluded on May 1.
-
Pork inventories in the U.S. increased 5.93 percent at the end of April from a year earlier, reaching a record high, the government said.
-
Hog futures climbed for the third straight session on speculation that record-high U.S. beef prices will encourage consumers to switch to cheaper pork. Cattle declined.
|
|
Most Popular on Bloomberg
|
| |
Rate this Page